Zaprinast
| Zaprinast | |
|---|---|
| Zaprinast.svg | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 37762-06-4 |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Zaprinast is a chemical compound that acts as a phosphodiesterase inhibitor. It was originally developed as a potential treatment for asthma and allergic rhinitis, but it is primarily used in research settings to study the role of phosphodiesterases in various biological processes.
Mechanism of Action[edit]
Zaprinast functions by inhibiting the activity of phosphodiesterase enzymes, particularly phosphodiesterase 5 (PDE5). By inhibiting PDE5, zaprinast prevents the breakdown of cyclic guanosine monophosphate (cGMP), leading to increased levels of cGMP within cells. This elevation in cGMP can result in various physiological effects, such as smooth muscle relaxation and vasodilation.
Pharmacological Effects[edit]
The primary pharmacological effect of zaprinast is the relaxation of smooth muscle tissue, which can lead to vasodilation. This effect is similar to that of other PDE5 inhibitors, such as sildenafil, which is used to treat erectile dysfunction and pulmonary arterial hypertension.
Research Applications[edit]
Zaprinast is widely used in research to study the role of phosphodiesterases in cellular signaling pathways. It has been used to investigate the mechanisms of smooth muscle relaxation, the regulation of vascular tone, and the modulation of inflammatory responses.
Chemical Properties[edit]
Zaprinast is a member of the purine class of compounds. Its chemical structure includes a purine ring system with a propoxyphenyl group attached. The molecular formula of zaprinast is C13H13N5O2.
Related Compounds[edit]
Zaprinast is structurally related to other phosphodiesterase inhibitors, such as sildenafil and vardenafil. These compounds share a similar mechanism of action but differ in their chemical structures and pharmacokinetic properties.
Related pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
